Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism

To maintain homeostasis under diverse metabolic conditions, it is necessary to coordinate nutrient-sensing pathways with the immune response. This coordination requires a complex relationship between cells, hormones, and cytokines in which inflammatory and metabolic pathways are convergent at multip...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Rull, Jordi Camps, Carlos Alonso-Villaverde, Jorge Joven
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2010/326580
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545952771080192
author Anna Rull
Jordi Camps
Carlos Alonso-Villaverde
Jorge Joven
author_facet Anna Rull
Jordi Camps
Carlos Alonso-Villaverde
Jorge Joven
author_sort Anna Rull
collection DOAJ
description To maintain homeostasis under diverse metabolic conditions, it is necessary to coordinate nutrient-sensing pathways with the immune response. This coordination requires a complex relationship between cells, hormones, and cytokines in which inflammatory and metabolic pathways are convergent at multiple levels. Recruitment of macrophages to metabolically compromised tissue is a primary event in which chemokines play a crucial role. However, chemokines may also transmit cell signals that generate multiple responses, most unrelated to chemotaxis, that are involved in different biological processes. We have reviewed the evidence showing that monocyte chemoattractant protein-1 (MCP-1 or CCL2) may have a systemic role in the regulation of metabolism that sometimes is not necessarily linked to the traffic of inflammatory cells to susceptible tissues. Main topics cover the relationship between MCP-1/CCL2, insulin resistance, inflammation, obesity, and related metabolic disturbances.
format Article
id doaj-art-d64d141663bc4f108f7e71789bce1d72
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-d64d141663bc4f108f7e71789bce1d722025-02-03T07:24:21ZengWileyMediators of Inflammation0962-93511466-18612010-01-01201010.1155/2010/326580326580Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of MetabolismAnna Rull0Jordi Camps1Carlos Alonso-Villaverde2Jorge Joven3Centre de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, c/ Sant Joan s/n, 43201 Reus, SpainCentre de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, c/ Sant Joan s/n, 43201 Reus, SpainServei de Medicina Interna, Hospital Son Llàtzer, 07198 Palma, SpainCentre de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, c/ Sant Joan s/n, 43201 Reus, SpainTo maintain homeostasis under diverse metabolic conditions, it is necessary to coordinate nutrient-sensing pathways with the immune response. This coordination requires a complex relationship between cells, hormones, and cytokines in which inflammatory and metabolic pathways are convergent at multiple levels. Recruitment of macrophages to metabolically compromised tissue is a primary event in which chemokines play a crucial role. However, chemokines may also transmit cell signals that generate multiple responses, most unrelated to chemotaxis, that are involved in different biological processes. We have reviewed the evidence showing that monocyte chemoattractant protein-1 (MCP-1 or CCL2) may have a systemic role in the regulation of metabolism that sometimes is not necessarily linked to the traffic of inflammatory cells to susceptible tissues. Main topics cover the relationship between MCP-1/CCL2, insulin resistance, inflammation, obesity, and related metabolic disturbances.http://dx.doi.org/10.1155/2010/326580
spellingShingle Anna Rull
Jordi Camps
Carlos Alonso-Villaverde
Jorge Joven
Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
Mediators of Inflammation
title Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
title_full Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
title_fullStr Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
title_full_unstemmed Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
title_short Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
title_sort insulin resistance inflammation and obesity role of monocyte chemoattractant protein 1 orccl2 in the regulation of metabolism
url http://dx.doi.org/10.1155/2010/326580
work_keys_str_mv AT annarull insulinresistanceinflammationandobesityroleofmonocytechemoattractantprotein1orccl2intheregulationofmetabolism
AT jordicamps insulinresistanceinflammationandobesityroleofmonocytechemoattractantprotein1orccl2intheregulationofmetabolism
AT carlosalonsovillaverde insulinresistanceinflammationandobesityroleofmonocytechemoattractantprotein1orccl2intheregulationofmetabolism
AT jorgejoven insulinresistanceinflammationandobesityroleofmonocytechemoattractantprotein1orccl2intheregulationofmetabolism